questionsmedicales.fr
Phénomènes chimiques
Phénomènes biochimiques
Conformation moléculaire
Conformation des protéines
Éléments structuraux des protéines
Motifs et domaines d'intéraction protéique
Motifs et domaines d'intéraction protéique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Protéines
Bioinformatique
Immunoprécipitation
Interactions protéiques
Bioinformatique
Modélisation moléculaire
Conformation protéique
Complexes protéiques
Mutations
Interactions protéiques
Symptômes
5
Dysfonction protéique
Maladies auto-immunes
Cancer
Maladie d'Alzheimer
Maladies génétiques
Fonctions cellulaires
Inflammation
Troubles neurologiques
Prévention
5
Prévention
Mode de vie sain
Dépistage
Maladies génétiques
Vaccins
Réponse immunitaire
Traitements
5
Médicaments
Anticorps monoclonaux
Thérapie génique
Mutations
Inhibiteurs de protéines
Options thérapeutiques
Traitements ciblés
Fonction cellulaire
Thérapies combinées
Efficacité du traitement
Complications
5
Cancers
Maladies neurodégénératives
Maladies auto-immunes
Réponses immunes
Troubles métaboliques
Déséquilibres
Facteurs de risque
5
Facteurs de risque
Génétique
Vieillissement
Stabilité protéique
Infections virales
Perturbations
Mode de vie
Alimentation déséquilibrée
Facteurs environnementaux
Toxines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Motifs et domaines d'intéraction protéique : Questions médicales les plus fréquentes",
"headline": "Motifs et domaines d'intéraction protéique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Motifs et domaines d'intéraction protéique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Motifs et domaines d'intéraction protéique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Éléments structuraux des protéines",
"url": "https://questionsmedicales.fr/mesh/D000072416",
"about": {
"@type": "MedicalCondition",
"name": "Éléments structuraux des protéines",
"code": {
"@type": "MedicalCode",
"code": "D000072416",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Domaine B30.2-SPRY",
"alternateName": "B30.2-SPRY Domain",
"url": "https://questionsmedicales.fr/mesh/D000071197",
"about": {
"@type": "MedicalCondition",
"name": "Domaine B30.2-SPRY",
"code": {
"@type": "MedicalCode",
"code": "D000071197",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.290"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine BTB-POZ",
"alternateName": "BTB-POZ Domain",
"url": "https://questionsmedicales.fr/mesh/D000071757",
"about": {
"@type": "MedicalCondition",
"name": "Domaine BTB-POZ",
"code": {
"@type": "MedicalCode",
"code": "D000071757",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.343"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Superfamille des domaines de mort",
"alternateName": "Death Domain Superfamily",
"url": "https://questionsmedicales.fr/mesh/D000071458",
"about": {
"@type": "MedicalCondition",
"name": "Superfamille des domaines de mort",
"code": {
"@type": "MedicalCode",
"code": "D000071458",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Domaine d'activation et de recrutement des caspases",
"alternateName": "Caspase Activation and Recruitment Domain",
"url": "https://questionsmedicales.fr/mesh/D000071476",
"about": {
"@type": "MedicalCondition",
"name": "Domaine d'activation et de recrutement des caspases",
"code": {
"@type": "MedicalCode",
"code": "D000071476",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine de mort",
"alternateName": "Death Domain",
"url": "https://questionsmedicales.fr/mesh/D000071459",
"about": {
"@type": "MedicalCondition",
"name": "Domaine de mort",
"code": {
"@type": "MedicalCode",
"code": "D000071459",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine effecteur de mort",
"alternateName": "Death Effector Domain",
"url": "https://questionsmedicales.fr/mesh/D000071461",
"about": {
"@type": "MedicalCondition",
"name": "Domaine effecteur de mort",
"code": {
"@type": "MedicalCode",
"code": "D000071461",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine pyrine",
"alternateName": "Pyrin Domain",
"url": "https://questionsmedicales.fr/mesh/D000071196",
"about": {
"@type": "MedicalCondition",
"name": "Domaine pyrine",
"code": {
"@type": "MedicalCode",
"code": "D000071196",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Domaines FERM",
"alternateName": "FERM Domains",
"url": "https://questionsmedicales.fr/mesh/D000075926",
"about": {
"@type": "MedicalCondition",
"name": "Domaines FERM",
"code": {
"@type": "MedicalCode",
"code": "D000075926",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.422"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines MYND",
"alternateName": "MYND Domains",
"url": "https://questionsmedicales.fr/mesh/D000074608",
"about": {
"@type": "MedicalCondition",
"name": "Domaines MYND",
"code": {
"@type": "MedicalCode",
"code": "D000074608",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.474"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines PDZ",
"alternateName": "PDZ Domains",
"url": "https://questionsmedicales.fr/mesh/D054731",
"about": {
"@type": "MedicalCondition",
"name": "Domaines PDZ",
"code": {
"@type": "MedicalCode",
"code": "D054731",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines à doigts de zinc de type RING",
"alternateName": "RING Finger Domains",
"url": "https://questionsmedicales.fr/mesh/D054829",
"about": {
"@type": "MedicalCondition",
"name": "Domaines à doigts de zinc de type RING",
"code": {
"@type": "MedicalCode",
"code": "D054829",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine d'homologie SRC",
"alternateName": "src Homology Domains",
"url": "https://questionsmedicales.fr/mesh/D018909",
"about": {
"@type": "MedicalCondition",
"name": "Domaine d'homologie SRC",
"code": {
"@type": "MedicalCode",
"code": "D018909",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Motif stérile alpha",
"alternateName": "Sterile Alpha Motif",
"url": "https://questionsmedicales.fr/mesh/D000071682",
"about": {
"@type": "MedicalCondition",
"name": "Motif stérile alpha",
"code": {
"@type": "MedicalCode",
"code": "D000071682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.813"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine Tudor",
"alternateName": "Tudor Domain",
"url": "https://questionsmedicales.fr/mesh/D000071856",
"about": {
"@type": "MedicalCondition",
"name": "Domaine Tudor",
"code": {
"@type": "MedicalCode",
"code": "D000071856",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.844"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines WW",
"alternateName": "WW Domains",
"url": "https://questionsmedicales.fr/mesh/D000074585",
"about": {
"@type": "MedicalCondition",
"name": "Domaines WW",
"code": {
"@type": "MedicalCode",
"code": "D000074585",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.937"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Motifs et domaines d'intéraction protéique",
"alternateName": "Protein Interaction Domains and Motifs",
"code": {
"@type": "MedicalCode",
"code": "D054730",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ylva Ivarsson",
"url": "https://questionsmedicales.fr/author/Ylva%20Ivarsson",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry-BMC, Uppsala University, Box 576, SE-751 23 Uppsala, Sweden. Electronic address: Yiva.ivarson@kemi.uu.se."
}
},
{
"@type": "Person",
"name": "Sobia Idrees",
"url": "https://questionsmedicales.fr/author/Sobia%20Idrees",
"affiliation": {
"@type": "Organization",
"name": "School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia."
}
},
{
"@type": "Person",
"name": "Keshav Raj Paudel",
"url": "https://questionsmedicales.fr/author/Keshav%20Raj%20Paudel",
"affiliation": {
"@type": "Organization",
"name": "Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia."
}
},
{
"@type": "Person",
"name": "Per Jemth",
"url": "https://questionsmedicales.fr/author/Per%20Jemth",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Biochemistry and Microbiology, Uppsala University, BMC Box 582, SE-75123 Uppsala, Sweden. Electronic address: Per.Jemth@imbim.uu.se."
}
},
{
"@type": "Person",
"name": "Norman E Davey",
"url": "https://questionsmedicales.fr/author/Norman%20E%20Davey",
"affiliation": {
"@type": "Organization",
"name": "Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Primary vaginal endodermal sinus tumor in infants and children: experience from a tertiary center.",
"datePublished": "2022-10-07",
"url": "https://questionsmedicales.fr/article/36207682",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12887-022-03634-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Primary endodermal sinus tumor originating from the sacral ligament: a case report and review of the literature.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37474890",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-023-05849-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endodermal Sinus Tumor of the Neck: A Rare Presentation.",
"datePublished": "2023-09-20",
"url": "https://questionsmedicales.fr/article/37868445",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.45630"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pseudo-Meigs syndrome secondary to endodermal sinus tumor.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36530560",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14744/nci.2020.45452"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endodermal sinus tumor with pancreatic origin: A case report.",
"datePublished": "2022-11-18",
"url": "https://questionsmedicales.fr/article/36413894",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijscr.2022.107783"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes chimiques",
"item": "https://questionsmedicales.fr/mesh/D055598"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes biochimiques",
"item": "https://questionsmedicales.fr/mesh/D001669"
},
{
"@type": "ListItem",
"position": 4,
"name": "Conformation moléculaire",
"item": "https://questionsmedicales.fr/mesh/D008968"
},
{
"@type": "ListItem",
"position": 5,
"name": "Conformation des protéines",
"item": "https://questionsmedicales.fr/mesh/D011487"
},
{
"@type": "ListItem",
"position": 6,
"name": "Éléments structuraux des protéines",
"item": "https://questionsmedicales.fr/mesh/D000072416"
},
{
"@type": "ListItem",
"position": 7,
"name": "Motifs et domaines d'intéraction protéique",
"item": "https://questionsmedicales.fr/mesh/D054730"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Motifs et domaines d'intéraction protéique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Motifs et domaines d'intéraction protéique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Motifs et domaines d'intéraction protéique",
"description": "Comment identifier un domaine d'interaction protéique ?\nQuels tests sont utilisés pour analyser les interactions protéiques ?\nLes motifs d'interaction peuvent-ils être prédits ?\nQuels marqueurs indiquent une interaction protéique ?\nComment les mutations affectent-elles les interactions protéiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Endodermal+Sinus+Tumor#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Motifs et domaines d'intéraction protéique",
"description": "Quels symptômes indiquent une dysfonction protéique ?\nLes interactions protéiques peuvent-elles causer des maladies ?\nComment les maladies génétiques affectent-elles les interactions ?\nQuels signes cliniques sont liés aux troubles d'interaction ?\nLes infections peuvent-elles perturber les interactions protéiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Endodermal+Sinus+Tumor#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Motifs et domaines d'intéraction protéique",
"description": "Comment prévenir les maladies liées aux interactions protéiques ?\nLes dépistages sont-ils utiles pour les troubles protéiques ?\nL'éducation sur les interactions protéiques est-elle importante ?\nLes vaccins influencent-ils les interactions protéiques ?\nComment le stress affecte-t-il les interactions protéiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Endodermal+Sinus+Tumor#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Motifs et domaines d'intéraction protéique",
"description": "Quels traitements ciblent les interactions protéiques ?\nComment la thérapie génique influence-t-elle les interactions ?\nLes inhibiteurs de protéines sont-ils efficaces ?\nComment les traitements ciblent-ils les motifs d'interaction ?\nLes thérapies combinées sont-elles bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Endodermal+Sinus+Tumor#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Motifs et domaines d'intéraction protéique",
"description": "Quelles complications peuvent survenir avec des interactions anormales ?\nLes complications sont-elles réversibles ?\nComment les interactions affectent-elles le vieillissement ?\nLes maladies auto-immunes sont-elles liées aux interactions ?\nLes troubles métaboliques sont-ils causés par des interactions ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Endodermal+Sinus+Tumor#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Motifs et domaines d'intéraction protéique",
"description": "Quels facteurs augmentent le risque de troubles protéiques ?\nLe vieillissement est-il un facteur de risque ?\nLes infections virales influencent-elles les interactions ?\nLe mode de vie peut-il affecter les interactions protéiques ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Endodermal+Sinus+Tumor#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un domaine d'interaction protéique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par des méthodes bioinformatiques et des expériences de biologie moléculaire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour analyser les interactions protéiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le co-immunoprécipitation et les essais de double hybride."
}
},
{
"@type": "Question",
"name": "Les motifs d'interaction peuvent-ils être prédits ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des outils bioinformatiques permettent de prédire les motifs d'interaction dans les protéines."
}
},
{
"@type": "Question",
"name": "Quels marqueurs indiquent une interaction protéique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de conformation ou des complexes protéiques stables peuvent indiquer une interaction."
}
},
{
"@type": "Question",
"name": "Comment les mutations affectent-elles les interactions protéiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mutations peuvent altérer la structure des motifs, perturbant ainsi les interactions normales."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dysfonction protéique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés comme la fatigue, des troubles métaboliques ou des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les interactions protéiques peuvent-elles causer des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions anormales peuvent contribuer à des maladies comme le cancer ou Alzheimer."
}
},
{
"@type": "Question",
"name": "Comment les maladies génétiques affectent-elles les interactions ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des défauts dans les motifs d'interaction, perturbant les fonctions cellulaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont liés aux troubles d'interaction ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'inflammation, la douleur ou des anomalies neurologiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles perturber les interactions protéiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains pathogènes modifient les interactions protéiques pour favoriser leur survie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux interactions protéiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Les dépistages sont-ils utiles pour les troubles protéiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages précoces peuvent aider à identifier des risques de maladies génétiques."
}
},
{
"@type": "Question",
"name": "L'éducation sur les interactions protéiques est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre les interactions peut aider à prévenir des maladies et à promouvoir la santé."
}
},
{
"@type": "Question",
"name": "Les vaccins influencent-ils les interactions protéiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent moduler les interactions immunitaires, renforçant la réponse du corps."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il les interactions protéiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut altérer les interactions protéiques, affectant la santé globale et le bien-être."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les interactions protéiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les inhibiteurs de protéines ou des anticorps monoclonaux sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment la thérapie génique influence-t-elle les interactions ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut corriger des mutations, rétablissant ainsi des interactions protéiques normales."
}
},
{
"@type": "Question",
"name": "Les inhibiteurs de protéines sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent bloquer des interactions spécifiques, offrant des options thérapeutiques."
}
},
{
"@type": "Question",
"name": "Comment les traitements ciblent-ils les motifs d'interaction ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils visent à modifier ou à bloquer des motifs spécifiques pour restaurer la fonction cellulaire."
}
},
{
"@type": "Question",
"name": "Les thérapies combinées sont-elles bénéfiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent cibler plusieurs interactions protéiques, améliorant l'efficacité du traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des interactions anormales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des cancers, des maladies neurodégénératives ou des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les interactions affectent-elles le vieillissement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interactions protéiques altérées peuvent accélérer le vieillissement cellulaire et tissulaire."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles liées aux interactions ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions anormales peuvent déclencher des réponses auto-immunes dans l'organisme."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques sont-ils causés par des interactions ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions protéiques défectueuses peuvent entraîner des déséquilibres métaboliques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles protéiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme la génétique, l'environnement et le mode de vie influencent le risque."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la stabilité et la fonction des interactions protéiques."
}
},
{
"@type": "Question",
"name": "Les infections virales influencent-elles les interactions ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent perturber les interactions protéiques, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter les interactions protéiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée et le manque d'exercice peuvent altérer les interactions."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des toxines ou des polluants peuvent affecter les interactions protéiques et la santé."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 17/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Chemistry-BMC, Uppsala University, Box 576, SE-751 23 Uppsala, Sweden. Electronic address: Yiva.ivarson@kemi.uu.se.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Microbiology, Uppsala University, BMC Box 582, SE-75123 Uppsala, Sweden. Electronic address: Per.Jemth@imbim.uu.se.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Dynamics of Macromolecular Assembly, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Dynamics of Macromolecular Assembly, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Structural Biology and NMR Laboratory and The Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology, Dwarka, New Delhi, 110078, India.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Computational and Structural Biology Laboratory, Division of Biotechnology, Netaji Subhas Institute of Technology, Dwarka, New Delhi, 110078, India.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology, Dwarka, New Delhi, 110078, India.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology, Dwarka, New Delhi, 110078, India. sbhatnagar@nsut.ac.in.
Computational and Structural Biology Laboratory, Division of Biotechnology, Netaji Subhas Institute of Technology, Dwarka, New Delhi, 110078, India. sbhatnagar@nsut.ac.in.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
School of Life Sciences, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
School of Life Sciences, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Australian Nuclear Science and Technology Organisation (ANSTO), Lucas Height, Australian Centre for Neutron Scattering, New South Wales 2234, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
School of Life Sciences, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Department of Molecular Sciences, Macquarie University, New South Wales 2109, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
The objective of the study was to analyze the clinical features, treatment, and outcomes of primary vaginal endodermal sinus tumor (EST) in infants and children treated in a tertiary center....
Clinical data of patients with pathologically confirmed primary vaginal EST in our hospital from January 1997 to December 2017 were retrospectively reviewed and analyzed....
A total of 21 patients were included in this study. The median age at diagnosis was 11 months (range, 4-44 months). The most common manifestations were abnormal vaginal bleeding, and a polypoid mass p...
Vaginal EST is a very rare malignant germ cell tumor and is sensitive to chemotherapy. Conservative surgery combined with PEB chemotherapy is an effective way of treatment. Serum AFP and imaging exami...
Endodermal sinus tumor (EST) is a malignant tumor originating from the ovary or testis. In most case, ultrasound examination shows ovarian mass. But there is a special kind of extra-gonadal endodermal...
A 14-year-old girl was admitted to the hospital because of acute lower abdominal pain. The ultrasound showed a mass with 72 mm × 64 mm × 50 mm in Douglas, and there was no abnormality in bilateral ova...
Extra-gonadal germ cell tumors are rarely reported. When young teenagers complain of acute lower abdominal pain with elevated AFP, but there was no lesion in bilateral ovaries and fallopian tubes, we ...
Germ cell tumors usually occur in the gonads. Extragonadal germ cell tumors (EGCTs) are uncommon, and the head and neck region is a rare primary location. In this region, endodermal sinus tumors are r...
Ovarian tumors are the most common gynecological tumors seen in girls. Approximately 60-70% of them are germ cell tumors. Pseudo-Meigs syndrome is characterized by the presence of pelvic tumoral mass ...
Endodermal Sinus tumor is a rare malignant type of germ cell tumor (GCT). Primary endodermal sinus tumor, especially in the head of pancreas, is extremely rare. The case under consideration is of a 22...
Endodermal sinus tumors are rare, especially extragonadal endodermal sinus tumors, which often occur in the midline of the brain, neck, chest, and abdomen....
We present the case of a 37-year-old woman with a mass on the right edge of the liver. Color Doppler ultrasound, computed tomography, and magnetic resonance imaging examinations were performed before ...
Primary endodermal sinus tumors on the abdominal wall near the right liver are easily misdiagnosed as hepatocellular carcinoma due to liver compression and elevated alpha-fetoprotein. The key point of...
Extragonadal endodermal sinus tumors often occur in the midline of the body. Here, we present a case of a primary endodermal sinus tumor on the abdominal wall near the right liver for the first time....
We herein report a case of an extremely rare spinal cord endodermal sinus tumor (EST). A nine-year-old boy presented with progressive paraparesis, hypesthesia, and urinary retention. Gadolinium-enhanc...
Yolk sac tumour (YST) is the second most common ovarian germ cell tumour and usually presents in children and young women. However, tumours rarely occur as malignant gynaecological tumours with YST co...
We present one case of endometrioid carcinoma and clear cell carcinoma with YST components and two other cases of YSTs associated with high-grade serous carcinoma of the ovary in females. After surger...
To our knowledge, these mixed neoplasm associations are unusual, and these cases illustrate the diagnosis and prognosis of YST associated with malignant gynaecological tumours, emphasizing early recog...
In this study, the authors sought to describe the cytologic features of primary gynecologic germ cell tumors and carcinomas exhibiting germ cell differentiation because little information currently ex...
An institutional database search was performed to identify histologically confirmed gynecologic germ cell tumors and carcinomas with germ cell tumor differentiation. Available cytologic material was r...
In total, 15 cytologic specimens from 12 women (aged 19-82 years) were identified and included touch preparations of core biopsies from various sites (n = 6), fine-needle biopsies (n = 2), pelvic wash...
Germ cell tumors and somatic neoplasms exhibiting germ cell tumor differentiation occurring in adult women share some cytologic features and may be difficult to distinguish from one another, although ...
Immune checkpoint blockade (ICB) is considered as a promising approach for cancer treatment. However, the potency of ICB therapy in yolk sac tumors (YSTs) has not been confirmed, and the comprehensive...
Immunohistochemistry was performed in formalin-fixed, paraffin-embedded tumor specimens from 23 YSTs patients to detect the density and distribution of tumor-infiltrating T cells, tertiary lymphoid st...
Overall, more than half (61 %) of all patients exhibited an immune-desert phenotype based on CD3...
Generally a high frequency of CTLA4 expression was found, PD-1/PD-L1 expression, the immune-inflamed phenotype, and TLSs were low frequency in YSTs, however, YSTs in testes showed a higher density of ...